Applied Therapeutics (APLT) Non-Current Assets (2023 - 2025)

Historic Non-Current Assets for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $2.7 million.

  • Applied Therapeutics' Non-Current Assets rose 3856.34% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 29188.18%. This contributed to the annual value of $3.0 million for FY2024, which is 58120.81% up from last year.
  • Per Applied Therapeutics' latest filing, its Non-Current Assets stood at $2.7 million for Q3 2025, which was up 3856.34% from $2.8 million recorded in Q2 2025.
  • In the past 5 years, Applied Therapeutics' Non-Current Assets registered a high of $3.0 million during Q4 2024, and its lowest value of $206000.0 during Q2 2024.
  • Its 3-year average for Non-Current Assets is $1.5 million, with a median of $941000.0 in 2023.
  • Per our database at Business Quant, Applied Therapeutics' Non-Current Assets crashed by 7503.03% in 2024 and then skyrocketed by 127427.18% in 2025.
  • Quarter analysis of 3 years shows Applied Therapeutics' Non-Current Assets stood at $447000.0 in 2023, then surged by 581.21% to $3.0 million in 2024, then decreased by 10.67% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, $2.8 million for Q2 2025, and $2.9 million during Q1 2025.